![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Fostemsavir and QT Prolongation: Clinical Applications for Co-administration With Other Agents
|
|
|
HIV Drug Therapy Glasgow; October 23-26, 2022; Virtual and Glasgow, Scotland
Sonia Patel,1 Vilma Vega,1 Alftan Dyson,1 Rakesh Guduru,2 Golkoo Morcos,1* Mónica Calderón,1 Andrew Mannebach,2 Bruce Gilliam,1 Andrew Clark,3 Allan Tenorio,1 Katy Moore1*
1ViiV Healthcare, Durham, NC, USA; 2GSK, Durham, NC, USA; 3ViiV Healthcare, Brentford, UK
*Employee of ViiV Healthcare at the time of the study.
resenting author: Alftan Dyson; alftan.x.dyson@viivhealthcare.com
![1031221](../images/103122/103122-16/1031221.gif)
![1031222](../images/103122/103122-16/1031222.gif)
![1031223](../images/103122/103122-16/1031223.gif)
![1031224](../images/103122/103122-16/1031224.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|